New Tool: ProSource
Checkout our packaging and processing solutions finder, ProSource.

Super-Potent Morphine Recalled

Three infants were impacted by use of the product, according to the FDA.

Pharmakon Pharmaceuticals is voluntarily recalling morphine sulfate 0.5 mg/mL preservative free in 0.9% sodium chloride, 1 mL syringe, CII, for intravenous use, because the product is super-potent, according to the FDA.

The recalled product was made on Feb. 3, with an expiration date of March 19, and distributed to two medical facilities, one in Indiana and one in Illinois.

On Feb. 16, the FDA was alerted of serious adverse events in three infants associated with the use of the recalled morphine sulfate products from Pharmakon.

It was not clear what exactly the incidents were.

 

How to Honor a Leader
Induction into the Packaging & Processing Hall of Fame is the highest honor in our industry. Submit your leader to be considered for the Class of 2024 now through June 10th. New members will be inducted at PACK EXPO International in Chicago.
Read More
How to Honor a Leader
Test Your Supply Chain Smarts
Take Healthcare Packaging's supply chain quiz to prove your knowledge!
Read More
Test Your Supply Chain Smarts